Visiopharm Engages in Major Initiative for Deep Learning in Tissue Based Pathology

Visiopharm Engages in Major Initiative for Deep Learning in Tissue Based Pathology
Hørsholm, Denmark, May 3rd - Visiopharm A/S announces the first result of their multifaceted strategy to apply Deep Learning technologies to its leading image analysis solution for cancer research and diagnostics. Visiopharm considers Deep Learning ...
Read more

Philips teams up with Visiopharm to boost breast cancer diagnosis objectivity through computational pathology

Philips teams up with Visiopharm to boost breast cancer diagnosis objectivity through computational pathology
• Breast cancer patients in Europe are set to benefit from more objective diagnosis • Philips’ digital pathology offering to be complemented with Visiopharm breast cancer panel algorithms Amsterdam, the Netherlands – Royal Philips (NYSE: PHG...
Read more

Worldwide collaboration for the Galileo Tissue Microarray – 100% traceable TMA workflow

Worldwide collaboration for the Galileo Tissue Microarray – 100% traceable TMA workflow
Today ISENET and Visiopharm announce a non-exclusive world-wide distribution agreement to provide Visiopharm image analysis with the Galileo TMA instrument, along with the Visiopharm Tissuearray™ imaging module, a part of ONCOTOPIX®, for tissue-ba...
Read more

Image Analysis: A Vital Tool for Drug Discovery

Image Analysis: A Vital Tool for Drug Discovery
An interview with Amanda Lowe, Senior Vice President and Andreas Schønau, Chief Scientific Officer of Visiopharm, a solution provider company at the marcus evans Discovery Summit 2015, on how quantitative digital pathology can enhance the drug disc...
Read more

New, Innovative Technologies for Quality Control of Immunohistochemistry

New, Innovative Technologies for Quality Control of Immunohistochemistry
Immunohistochemistry (IHC) stained tissue sections are read and interpreted by a pathologist using a microscope, or on a computer monitor as routine use of digital pathology continues to grow. Regardless of interpretation method, It is well known and...
Read more

Aarhus University Hospital Selects Visiopharm for Cancer Diagnostics

Aarhus University Hospital Selects Visiopharm for Cancer Diagnostics
After thorough testing, and internal clinical validation, Aarhus University Hospital selects Visiopharm’s ONCOtopix™ Dx – a platform for computer assisted quantitative diagnostic immunohistochemistry (IHC) and In-Situ Hybridization (ISH). At ...
Read more